Skip to main content

Table 2 Previous number of bDMARDs administered

From: Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort

Number of bDMARDs received

Total group % (n)

Standard care group % (n)

Dose reduction group % (n)

1

53.3 (177)

49.5 (96)

57.6 (81)

2

29.5 (98)

32.1 (61)

26.6 (37)

3

8.4 (28)

8.3 (16)

8.5 (12)

4

5.7 (19)

6.3 (12)

5.0 (7)

5

2.4 (8)

2.6 (5)

2.2 (3)

6

0.6 (2)

1.1 (2)

0 (0)

Total

100 (332)

100 (192)

100 (140)